Drug Shortage Report for AMPICILLIN SODIUM FOR INJECTION, USP

Last updated on 2019-11-07 History
Report ID 87653
Drug Identification Number 00872652
Brand name AMPICILLIN SODIUM FOR INJECTION, USP
Common or Proper name AMPICILLIN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) AMPICILLIN
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 10 PK
ATC code J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-06-24
Estimated end date 2019-11-30
Actual end date 2019-11-06
Shortage status Resolved
Updated date 2019-11-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2019-11-07 French Compare
v13 2019-11-07 English Compare
v12 2019-10-31 French Compare
v11 2019-10-31 English Compare
v10 2019-10-03 French Compare
v9 2019-10-03 English Compare
v8 2019-09-05 French Compare
v7 2019-09-05 English Compare
v6 2019-08-29 French Compare
v5 2019-08-29 English Compare
v4 2019-08-09 French Compare
v3 2019-08-09 English Compare
v2 2019-06-27 French Compare
v1 2019-06-27 English Compare

Showing 1 to 14 of 14